Accendra Health, Inc. (ACH) Q1 FY26 Earnings Call

Underlying growth was positive after the payer exit, but refinancing raises annual cash interest by approximately $40 million.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Length35 minutes
EPS$-0.04
EPS consensus$-0.06
Revenue$627.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All ACH earnings ยท Back to ACH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.